300 related articles for article (PubMed ID: 35216709)
21. Prevalence of undiagnosed testosterone deficiency in aging athletes: does exercise training influence the symptoms of male hypogonadism?
Di Luigi L; Sgrò P; Fierro V; Bianchini S; Battistini G; Magini V; Jannini EA; Lenzi A
J Sex Med; 2010 Jul; 7(7):2591-601. PubMed ID: 20141589
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of hypogonadism in patients with type 2 diabetes mellitus among the Indian population.
Anupam B; Shivaprasad C; Vijaya S; Sridevi A; Aiswarya Y; Nikhil K
Diabetes Metab Syndr; 2020; 14(5):1299-1304. PubMed ID: 32755825
[TBL] [Abstract][Full Text] [Related]
23. [Relevant clinical and biological criteria for the diagnosis of androgen deficiency in the aging male (ADAM)].
Seisen T; Rouprêt M; Gallais JL; Costa P
Prog Urol; 2012 Jun; 22 Suppl 1():S21-6. PubMed ID: 22770497
[TBL] [Abstract][Full Text] [Related]
24. Hypogonadism in men receiving methadone and buprenorphine maintenance treatment.
Hallinan R; Byrne A; Agho K; McMahon CG; Tynan P; Attia J
Int J Androl; 2009 Apr; 32(2):131-9. PubMed ID: 17971165
[TBL] [Abstract][Full Text] [Related]
25. [Male hypogonadotropic hypogonadism (MHH) outpatient with testosterone deficiency syndrome: a case report].
Taniguchi H; Kawa G; Kinoshita H; Matsuda T; Asai A
Hinyokika Kiyo; 2009 Feb; 55(2):107-9. PubMed ID: 19301617
[TBL] [Abstract][Full Text] [Related]
26. Clomiphene citrate and enclomiphene for the treatment of hypogonadal androgen deficiency.
Kaminetsky J; Hemani ML
Expert Opin Investig Drugs; 2009 Dec; 18(12):1947-55. PubMed ID: 19938905
[TBL] [Abstract][Full Text] [Related]
27. Low testosterone and the association with type 2 diabetes.
Farrell JB; Deshmukh A; Baghaie AA
Diabetes Educ; 2008; 34(5):799-806. PubMed ID: 18832284
[TBL] [Abstract][Full Text] [Related]
28. Late onset hypogonadism in type 2 diabetic and nondiabetic male: a comparative study.
Basu AK; Singhania P; Bandyopadhyay R; Biswas K; Santra S; Singh S; Mukherjee SK; Raychaudhuri P
J Indian Med Assoc; 2012 Aug; 110(8):573-5. PubMed ID: 23741825
[TBL] [Abstract][Full Text] [Related]
29. Clinical aspects of androgen deficiency in men.
Nicholls DP; Anderson DC
Andrologia; 1982; 14(5):379-88. PubMed ID: 6890781
[TBL] [Abstract][Full Text] [Related]
30. A study to evaluate the prevalence of hypogonadism in Indian males with Type-2 diabetes mellitus.
Agarwal PK; Singh P; Chowdhury S; Sharma SK; Majumdar A; Shah P; Sahay R; Ayyar SV; Phatale H; Batra CM; Syed R; Shetty P
Indian J Endocrinol Metab; 2017; 21(1):64-70. PubMed ID: 28217500
[TBL] [Abstract][Full Text] [Related]
31. Oestrone, oestradiol and testosterone in normal and hypogonadal men following LH-RH or HCG stimulation.
Kley HK; Nieschlag E; Wiegelmann W; Krüskemper HL
Acta Endocrinol (Copenh); 1976 Mar; 81(3):616-22. PubMed ID: 766550
[TBL] [Abstract][Full Text] [Related]
32. Testosterone replacement-induced hyperprolactinaemia: case report and review of the literature.
Sodi R; Fikri R; Diver M; Ranganath L; Vora J
Ann Clin Biochem; 2005 Mar; 42(Pt 2):153-9. PubMed ID: 15829128
[TBL] [Abstract][Full Text] [Related]
33. Osteoporosis in men with hyperprolactinemic hypogonadism.
Greenspan SL; Neer RM; Ridgway EC; Klibanski A
Ann Intern Med; 1986 Jun; 104(6):777-82. PubMed ID: 3706929
[TBL] [Abstract][Full Text] [Related]
34. Return of gonadal function with resection of nonfunctioning pituitary adenoma.
Ober KP; Kelly DL
Neurosurgery; 1988 Feb; 22(2):386-7. PubMed ID: 3352889
[TBL] [Abstract][Full Text] [Related]
35. Effects of testosterone replacement therapy on bone metabolism in male post-surgical hypogonadotropic hypogonadism: focus on the role of androgen receptor CAG polymorphism.
Tirabassi G; delli Muti N; Gioia A; Biagioli A; Lenzi A; Balercia G
J Endocrinol Invest; 2014 Apr; 37(4):393-400. PubMed ID: 24458833
[TBL] [Abstract][Full Text] [Related]
36. [Secondary male hypogonadism induced by sellar space-occupying lesion: Clinical analysis of 22 cases].
Lu HL; Wang T; Xu H; Chen LP; Rao K; Yang J; Yuan HX; Liu JH
Zhonghua Nan Ke Xue; 2016 Aug; 22(8):704-709. PubMed ID: 29019226
[TBL] [Abstract][Full Text] [Related]
37. Osteoporotic fractures in patients with untreated hyperprolactinemia vs. those taking dopamine agonists: A systematic review and meta-analysis.
D'Sylva C; Khan T; Van Uum S; Fraser LA
Neuro Endocrinol Lett; 2015; 36(8):745-9. PubMed ID: 26921574
[TBL] [Abstract][Full Text] [Related]
38. GH-induced LH hyporesponsiveness as a potential mechanism for hypogonadism in male patients with acromegaly.
Nishio R; Takeshita A; Uchida T; Herai T; Sakamoto K; Shimizu Y; Arai M; Tatsushima K; Fukuhara N; Okada M; Nishioka H; Yamada S; Koibuchi N; Watada H; Takeuchi Y
Endocr J; 2021 Aug; 68(8):953-968. PubMed ID: 33840669
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of relationships between plasma androgens level and clinical signs of hipoandrogenism according to age and comorbidity of metabolic syndrome in men].
Herman WA; Krzoska A; Pawliczak E; Roszak M; Łacka K
Pol Merkur Lekarski; 2014 Jan; 36(211):16-21. PubMed ID: 24645572
[TBL] [Abstract][Full Text] [Related]
40. Testosterone replacement in men.
Beg S; Al-Khoury L; Cunningham GR
Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):364-70. PubMed ID: 18594278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
